1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Jaguar Health, Inc.

Jaguar Health, Inc.

JAGX
Jaguar Health, Inc.US flagNASDAQ Capital Market
2.63
USD
-0.19
- -
5.12MMarket Cap

Total Valuation

Jaguar Health, Inc. carries a market capitalization of 5.12M, placing it among publicly traded companies globally. Its enterprise value stands at 231.40M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap5.12M
Enterprise Value231.40M

Share Statistics

Jaguar Health, Inc. currently has 4.86M shares outstanding.

Shares Outstanding4.86M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.47, and the price-to-book ratio stands at 33.04.

PE RatioN/A
PS Ratio0.47
PB Ratio33.04
P/TBV Ratio-25.80
P/FCF Ratio-1.96
P/OCF Ratio-1.95

Enterprise Valuation

EV / Sales8.33
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Jaguar Health, Inc. maintains a current ratio of 0.69, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 371.96, indicating elevated leverage, while an interest coverage ratio of -32.81 demonstrates limited ability to service its debt obligations.

Current Ratio0.69
Quick Ratio0.16
Debt / Equity371.96
Debt / EBITDA-0.80
Interest Coverage-32.81

Financial Efficiency

Return on Equity (ROE)-862.83
Return on Assets (ROA)-88.27
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)-95.23
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.55

Stock Price Statistics

Jaguar Health, Inc.'s stock has declined approximately -99.77229% over the past 52 weeks. The 50-day moving average sits at 8.39, while the 200-day moving average is 142.74.

Beta (5Y)N/A
52-Week Price Change-99.77229%
50-Day Moving Average8.39
200-Day Moving Average142.74
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Jaguar Health, Inc. generated 27.79M in revenue and converted that into -36.40M in net income, yielding earnings per share of -127.74. EBITDA reached -22.93M, while operating income came in at -25.09M.

Revenue27.79M
Gross Profit22.87M
Operating Income-25.09M
Pretax Income-36.92M
Net Income-36.40M
EBITDA-22.93M
EBIT-25.09M
Earnings Per Share (EPS)-127.74

Balance Sheet

Jaguar Health, Inc. holds 3.79M in cash and equivalents against 18.30M in total debt, resulting in a net debt position of 13.42M. Total book value stands at 6.62M, with working capital of -7.85M providing operational flexibility.

Cash & Cash Equivalents3.79M
Total Debt18.30M
Net Debt13.42M
Equity (Book Value)6.62M
Book Value Per Share1.36
Working Capital-7.85M

Cash Flow

Jaguar Health, Inc. produced -6.68M in operating cash flow over the past twelve months. After subtracting -41,000.00 in capital expenditures, free cash flow totaled -6.73M - equivalent to -23.27 per share.

Operating Cash Flow-6.68M
Capital Expenditures-41,000.00
Free Cash Flow-6.73M
FCF Per Share-23.27

Margins

Jaguar Health, Inc. operates with a gross margin of 82.29, reflecting its pricing power and cost economics. The operating margin of -90.30 and net profit margin of -130.97 provide insight into operational efficiency.

Gross Margin82.29
Operating Margin-90.30
Pretax Margin-132.85
Profit Margin-130.97
EBITDA Margin-82.52

Dividends & Yields

The company's payout ratio of 29.78 indicates the proportion of earnings distributed to shareholders.

Dividend Per ShareN/A
Dividend YieldN/A
Payout Ratio29.78
Shareholder Yield-5.17
FCF Yield-51.08

Stock Splits

Jaguar Health, Inc.'s most recent stock split took place on September 17, 2026 with a 15:1 split ratio.

Last Split Date9/17/2026
Split Ratio15:1

Scores

Jaguar Health, Inc. posts an Altman Z-Score of -28.47, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-28.47